Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Using central - not cuff - BP controls hypertension at lower doses

  • Print
  • Comments (2)
  • Save

bp

Treatment decisions based on central, rather than arm cuff, blood pressures result in patients being controlled at lower doses of antihypertensives, suggests a paper published today in Hypertension.

Australian researchers randomised 286 patients with hypertension to treatment decisions guided by best-practice usual care (which could be office, home or 24-hour ambulatory BP) or usual care plus central BP measurement using a SphygmoCor device.  In the latter group treatment decisions were based on the central BP measurement.

For usual care alone, there was no change in daily defined dose (DDD) of antihypertensive but there was a significant stepwise decrease in DDD from baseline to three months and at two subsequent three monthly reviews in those in the central BP group.

But there were no differences between groups in left ventricular mass index, 24-hour ambulatory BP, home systolic BP, or aortic stiffness.

The researchers conclude that hypertension management with central BP results in a significantly different therapeutic pathway than conventional cuff BP, with less use of medication to achieve BP control and no adverse effects on left ventricular mass, aortic stiffness, or quality of life.

Readers' comments (2)

  • Another important clinical study that shows the clinical relevance of measuring central BP in managing therapeutic pathways in hypertension management with probable reduction in therapeutic costs and better outcomes for patients. How many more studies must be done to prove clinical efficacy before such technology is adopted as a clinical norm? Come on NICE, take a lead and get this technology adopted into mainstream hypertension diagnosis and management for the benefit of patients and save the NHS millions of ££££'s off the nations anti-hypertensive drugs bill!

    Unsuitable or offensive? Report this comment

  • As a registered nutritional therapist I have been measuring central BP as part of my Irish Heart Health service for close on 5 years, this is a very straight forward technology, and gives the client a picture of where their CV health is heading. The combination of targeted nutrition and smart supplements show reductions in as little as 8 weeks. The incidence of raised central BP is very common.

    Unsuitable or offensive? Report this comment

Have your say

  • Print
  • Comments (2)
  • Save